Catalyst Wire Dossier Catalyst Wire Dossier

P501-AS15 Vaccine

P501-AS15 vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for P501-AS15 Vaccine, covering 2017-06-02 to 2017-06-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA [Phase 1]

See pricing